Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 17 , ISSUE 2 ( July-December, 2015 ) > List of Articles

Original Article

A clinicomicrobiological study of diabetic foot ulcers from South Kerala

Suryakala R. Nair, Sharada Devi Karunakaran Lalithabhai

Keywords : Diabetic foot infections, multidrug-resistant organisms (MDRO), methicillin-resistant Staphylococcus aureus (MRSA)

Citation Information : Nair SR, Lalithabhai SD. A clinicomicrobiological study of diabetic foot ulcers from South Kerala. 2015; 17 (2):94-99.

DOI: 10.4103/0972-1282.171890

License: CC BY-NC-SA 4.0

Published Online: 15-07-2024

Copyright Statement:  Copyright © 2015; Wolters Kluwer India Pvt. Ltd.


Abstract

Background: Infection with multidrug-resistant organisms (MDRO) in foot ulcers is a major cause of morbidity and mortality among diabetic patients in India. The empirical antibacterial therapy based on local prevalence and susceptibility pattern of bacterial isolates can significantly reduce the incidence of complications. Objectives: The study aimed to a) determine the microbiological profile and prevalence of MDRO isolated from diabetic foot infection; b) identify the main risk factors for MDRO; and c) find out the risk of a few selected complications in ulcers infected with MDRO. Materials and Methods: Specimens such as tissue/bone biopsy or syringe aspirates were collected for culture and antimicrobial sensitivity testing from patients with diabetic foot ulcers of Wagner grade ≥2. Cefoxitin disc diffusion method was used for the detection of methicillin-resistant Staphylococcus aureus (MRSA). Standard methods to detect ESBLs, AmpC β-lactamase, and metallo-beta-lactamase were used in multidrug-resistant Gram-negative isolates. Results: Out of 250 patients, 144 (58.3%) had polymicrobial infection and 172 (41.7%) of the 412 isolates were multidrug-resistant. Staphylococcus aureus was the single commonest organism, i.e., 139 (33.7%). Out of 139 Staphylococcus aureus isolates, 62 (44.6%) were MRSA. Gram-negative organisms accounted for the majority of isolates, i.e., 223 (54.1%). Out of 223 Gram-negative organisms, 108 (48.4%) were multidrug-resistant. The commonest Gram-negative bacterium was Pseudomonas aeruginosa, i.e., 77/223 (18.7%). Risk factors for MDRO and outcome of MDRO infection were also analysed. Conclusions: The prevalence of MDRO in our study was nearly 50%, which shows the urgent need for implementation of strict antibiotic policy and infection control measures to avoid antibiotic resistance. The presence of recurrent ulcer, past hospital stay, past foot-related surgery, ulcer size (>4 cm2) and ulcer duration >1 week were identified as the main risk factors for MDRO. Death during hospital stay was significantly higher in the MDRO group, while ulcer healing or amputation was not significantly associated. Finally, an empirical antibiotic policy was also proposed for treating diabetic foot infections.


PDF Share
  1. Wagner FW. The dysvascular foot: A system of diagnosis and treatment. Foot Ankle 1981;2:64-122.
  2. Chaudhary U, Aggarwal R. Extended spectrum -lactamases (ESBL) - An emerging threat to clinical therapeutics. Indian J Med Microbiol 2004;22:75-80.
  3. Hemalatha V, Padma M, Sekar U, Vinodh TM, Arunkumar AS. Detection of Amp C β lactamases production in E.coli and Klebsiella by an inhibitor based method. Indian J Med Res 2007;126:220-3.
  4. Young D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamases producing clinical isolates of Pseudomonas species and Acinetobacter species. J Clin Microbiol 2002;40:3798-801.
  5. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006;29:1727-32.
  6. Shanker EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. Eur J intern Med 2005;16:567-70.
  7. Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 2008,51:204-7.
  8. Chincholikar DA, Pal RB. Study of fungal and bacterial infections of the diabetic foot. Indian J Pathol Microbiol 2002;45:15-22.
  9. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabetes Complications 2005;19:138-41.
  10. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007;45:2819-28.
  11. Anandi C, Alaguraja D, Natarajan V, Ramanathan M, Subramaniam CS, Thulasiram M, et al. Bacteriology of diabetic foot lesions. Indian J Medical Microbiol 2004;22:175-8.
  12. Viswanathan V, Thomas N, Tandon N, Asirvatham A, Rajasekar S, Ramachandran A, et al. Profile of diabetic foot complications and its associated complications - A multicentric study from India. J Assoc Physicians India 2005;53:933-6.
  13. Raja NS. Microbiology of diabetic foot infection in a teaching hospital in Malaysia-a retrospective study of 194 cases. J Microbiol Immunol Infect 2007;40:39-44.
  14. Varaiya A, Dogra J, Kulkarni M, Bhalekar P. Extended spectrum beta lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infections. Indian J Med Microbiol 2008;26:281-2.
  15. Varaiya A, Kulkarni M, Bhalekar P, Dogra J. Incidence of carabapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients. Indian J Medical Microbiol 2008;26:238-40.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.